PE-backed Cousin Medical Group buys FR2D

Cousin Medical intends to expand internationally in the coming years, notably thanks to the network of FR2D's CEO, Erik Boulard, according to a statement.

The bolt-on transaction was supported by debt provided by a pool of banks, according to a statement.  

Turenne acquired a majority stake in Cousin Medical in Q3 this year, using its Capital Santé 2 fund. The fund, still on the fundraising trail, held a first close on €100m in March. The investment in Cousin Medical is the fund's second deal.

Previous backer Dalle & Associés, as well as new investor Altur Investissement, also invested in the business, acquiring minority stakes.

Cousin Medical generates revenues of €22m, according to a statement published in April.

Company
Founded in 2009 and based in Sallebœuf, FR2D is a distributor of spine implants and surgery equipment. The business expects revenues of €4m this year.

People
France Rachis Distribution et Developpement – Erik Boulard (CEO).

Advisers
Equity – Logion Finance (M&A); Lamartine Conseil (legal); Aequifi (financial due diligence).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• France
• Healthcare
• France
• Turenne Capital Partenaires
• Build-up